Format

Send to

Choose Destination
Clin Gastroenterol Hepatol. 2013 Sep;11(9):1050-63. doi: 10.1016/j.cgh.2013.02.024. Epub 2013 Mar 13.

Diagnosis and treatment of gastrointestinal disorders in patients with primary immunodeficiency.

Author information

1
Division of Clinical Immunology, Mount Sinai School of Medicine, New York, New York 10029, USA. shradha.agarwal@mssm.edu

Abstract

Gastrointestinal disorders such as chronic or acute diarrhea, malabsorption, abdominal pain, and inflammatory bowel diseases can indicate immune deficiency. The gastrointestinal tract is the largest lymphoid organ in the body, so it is not surprising that intestinal diseases are common among immunodeficient patients. Gastroenterologists therefore must be able to diagnose and treat patients with primary immunodeficiency. Immune-related gastrointestinal diseases can be classified as those that develop primarily via autoimmunity, infection, an inflammatory response, or malignancy. Immunodeficient and immunocompetent patients with gastrointestinal diseases present with similar symptoms. However, intestinal biopsy specimens from immunodeficient patients often have distinct histologic features, and these patients often fail to respond to conventional therapies. Therefore, early recognition of symptoms and referral to an immunologist for a basic immune evaluation is required to select appropriate treatments. Therapies for primary immunodeficiency comprise immunoglobulin replacement, antibiotics, and, in severe cases, bone marrow transplantation. Treatment of immunodeficient patients with concomitant gastrointestinal disease can be challenging, and therapy with immunomodulators often is required for severe disease. This review aims to guide gastroenterologists in the diagnosis and treatment of patients with primary immunodeficiency.

KEYWORDS:

6-MP; AZA; CGD; CVID; FOXP3; GI; GVHD; Hypogammaglobulinemia; IBD; IL; IPEX; Ig; Immune System; Inflammatory Intestinal Disease; NLH; SCID; STAT; TNF; WAS; WASp; Wiskott–Aldrich syndrome; Wiskott–Aldrich syndrome protein; X-linked agammaglobulinemia; XLA; azathioprine; chronic granulomatous disease; common variable immunodeficiency; forkhead box P3; gastrointestinal; graft-versus-host disease; immune dysfunction, polyendocrinopathy, enteropathy, X-linked; immunoglobulin; inflammatory bowel disese; interleukin; mercaptopurine; nodular lymphoid hyperplasia; severe combined immunodeficiency; signal transducer and activator of transcription; tumor necrosis factor

PMID:
23501398
PMCID:
PMC3800204
DOI:
10.1016/j.cgh.2013.02.024
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center